Home Medicine Prevalence of abnormal thyroid stimulating hormone and thyroid peroxidase antibody-positive results in a population of pregnant women in the Samara region of the Russian Federation
Article
Licensed
Unlicensed Requires Authentication

Prevalence of abnormal thyroid stimulating hormone and thyroid peroxidase antibody-positive results in a population of pregnant women in the Samara region of the Russian Federation

  • Frank A. Quinn , Gennady N. Gridasov , Sergey A. Vdovenko , Natalia A. Krasnova , Nadezhda V. Vodopianova , Marina A. Epiphanova and Monika Schulten
Published/Copyright: October 19, 2005

Abstract

Undiagnosed thyroid disease is a common problem with significant public health implications. This is especially true during pregnancy, when the health of both the mother and the developing child can be adversely affected by abnormal maternal thyroid function. Measurement of serum thyroid stimulating hormone (TSH) and thyroid peroxidase antibodies (TPO-Ab) are two common ways to assess maternal thyroid status. The objective of our study was to determine the prevalence of abnormal TSH and TPO-Ab tests in a population of pregnant women in the Samara region of the Russian Federation. Serum samples were obtained from 1588 pregnant women as part of their routine antenatal care. TSH and TPO-Ab were measured, and trimester-specific reference values for TSH (2.5–97.5 percentiles) were calculated using TPO-Ab-negative women. TSH results outside these ranges were considered abnormal; TPO-Ab levels outside the manufacturer's reference range (>12IU/mL) were considered abnormal. Overall, the prevalence of abnormal results was 6.3% for TSH and 10.7% for TPO-Ab. High TSH (>97.5 trimester-specific percentile) and TPO-Ab-positive results were most common in the first trimester (5.7% and 13.8%, respectively). TSH levels were associated with gestational age and TPO-Ab status, and with maternal age in TPO-Ab-negative women. TPO-Ab status was associated with both maternal and gestational age. Women with TSH >2.5mIU/L had a significantly increased risk of being TPO-Ab-positive, and this risk increased with age. Based on our data, we conclude that abnormal TSH and TPO-Ab are common in pregnant women of the Samara region. Given the association of thyroid dysfunction to adverse pregnancy outcomes, screening of this population for abnormal thyroid function should be considered.


Corresponding author: Frank A. Quinn, Abbott Laboratories, Abbott Park, IL, USA

References

1. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Maternal thyroid hormone early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004; 18:225–48.10.1016/j.beem.2004.03.012Search in Google Scholar PubMed

2. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13:1–104.Search in Google Scholar

3. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341:549–55.10.1056/NEJM199908193410801Search in Google Scholar PubMed

4. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000; 7:127–30.10.1136/jms.7.3.127Search in Google Scholar PubMed

5. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005; 105:239–45.10.1097/01.AOG.0000152345.99421.22Search in Google Scholar PubMed

6. Poppe K, Glinoer D. Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod Update 2003; 9:149–61.10.1093/humupd/dmg012Search in Google Scholar PubMed

7. Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and the risk of miscarriage. Best Pract Res Clin Endocrinol Metab 2004; 18:167–81.10.1016/j.beem.2004.03.007Search in Google Scholar PubMed

8. Poppe K, Glinoer D, Tournaye H, Devroey P, van Steirteghem A, Kaufman L, et al. Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab 2003; 88:4149–52.10.1210/jc.2003-030268Search in Google Scholar PubMed

9. Canaris GJ, Manowitz NR, Mayor G, Ridgeway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160:526–34.10.1001/archinte.160.4.526Search in Google Scholar PubMed

10. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87:489–99.10.1210/jcem.87.2.8182Search in Google Scholar PubMed

11. Glinoer D. The regulation of thyroid function during normal pregnancy: importance of iodine nutrition status. Best Pract Res Clin Endocrinol Metab 2004; 18:133–52.10.1016/j.beem.2004.03.001Search in Google Scholar PubMed

12. Mandel SJ, Spencer CA, Hollowell JG. Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid 2005; 15:44–53.10.1089/thy.2005.15.44Search in Google Scholar PubMed

13. Brent G, Boyle CA. The impact of maternal thyroid diseases on the developing fetus: implications for diagnosis, treatment, and screening. Summary of proceedings, workshop organization, program, and participants. Thyroid 2005; 15:36–8.10.1089/thy.2005.15.36Search in Google Scholar PubMed

Received: 2005-6-2
Accepted: 2005-8-16
Published Online: 2005-10-19
Published in Print: 2005-11-1

©2005 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region
  2. Isotretinoin therapy induces DNA oxidative damage
  3. Structural evaluation of plasma α2-macroglobulin in acute pancreatitis
  4. Failure of the PAXgene™ Blood RNA System to maintain mRNA stability in whole blood
  5. Reticulocyte hemoglobin measurement – comparison of two methods in the diagnosis of iron-restricted erythropoiesis
  6. Physical analysis of ejaculate to evaluate the secretory activity of the seminal vesicles and prostate
  7. Specificity of the 3H-triolein assay for pancreatic lipase in blood plasma
  8. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice
  9. Plasma levels of 7-hydroxymetabolites of dehydroepiandrosterone in healthy Central European aging men
  10. Prevalence of abnormal thyroid stimulating hormone and thyroid peroxidase antibody-positive results in a population of pregnant women in the Samara region of the Russian Federation
  11. Impact of standardized calibration on the inter-assay variation of 14 automated assays for the measurement of creatinine in human serum
  12. Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis
  13. Mean and variance quality control for multiple correlated levels of replicated control samples
  14. Clinical evaluation of serodiagnosis of active tuberculosis by multiple-antigen ELISA using lipids from Mycobacterium bovis BCG Tokyo 172
  15. Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010
  16. Unusually high alkaline phosphatase due to intestinal isoenzyme in a healthy adult
  17. Deficient α-galactosidase A activity in plasma but no Fabry disease – a pitfall in diagnosis
  18. Reportable interval of patient examination results and ISO 15189
Downloaded on 7.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.212/html
Scroll to top button